跳至主要内容
临床试验/ISRCTN13255144
ISRCTN13255144已完成2 期

A randomised phase II trial of dexamethasone and aspirin (DA) versus dexamethasone, diethylstilboestrol and aspirin (DAS) in locally advanced or metastatic cancer of the prostate

Department of Health (UK)0 个研究点目标入组 260 人开始时间: 2003年9月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
260

研究概览

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • North East Thames region (Whipps Cross, Oldchurch, King George, St. Bartholomew's).
  • Patients over the age of 18 years who have locally advanced metastatic prostate specific antigen (PSA)-positive adenocarcinoma after failure of gonadotropin releasing hormone (GnRH) analogue therapy, radiation therapy, surgery or any combination of these.

排除标准

  • Not provided at time of registration

研究者

发起方
Department of Health (UK)

相似试验

A randomised phase II trial of dexamethasone and... | 临床试验